Your Good Partner in Biology Research

Human cartilage oligomeric protein,COMP ELISA Kit

  • 中文名称:
    人软骨寡聚蛋白(COMP)酶联免疫试剂盒
  • 货号:
    CSB-E09138h
  • 规格:
    96T/48T
  • 价格:
    ¥3200/¥2500
  • 其他:

产品详情

  • 产品描述:
        COMP,全名Cartilage oligomeric matrix protein,是一种在软骨和其他组织中表达的蛋白质,参与细胞外基质的形成和维护等生物过程。它与骨关节炎、关节软骨损伤等疾病相关,同时在骨质疏松症和心血管疾病等疾病中也具有重要作用。COMP还被认为是一种可行的生物标志物,有助于相关疾病的诊断和治疗。
        j9九游会登录入口首页生物所提供的Human cartilage oligomeric protein,COMP ELISA Kit属于ELISA检测试剂盒,采用双抗夹心法定量检测人血清、血浆、组织匀浆样本中的COMP,其灵敏度为0.039 ng/ml,检测范围为0.156 ng/ml-10 ng/ml。
     
  • 别名:
    cartilage oligomeric matrix protein (pseudoachondroplasia; epiphyseal dysplasia 1; multiple) ELISA Kit; Cartilage oligomeric matrix protein ELISA Kit; Cartilage oligomeric matrix protein precursor ELISA Kit; COMP ELISA Kit; COMP_HUMAN ELISA Kit; EDM 1 ELISA Kit; EDM1 ELISA Kit; EPD 1 ELISA Kit; EPD1 ELISA Kit; Epiphyseal dysplasia 1 ELISA Kit; Epiphyseal dysplasia 1 multiple ELISA Kit; Epiphyseal dysplasia multiple 1 ELISA Kit; MED ELISA Kit; MGC13181 ELISA Kit; MGC149768 ELISA Kit; PSACH ELISA Kit; pseudoachondroplasia (epiphyseal dysplasia 1; multiple) ELISA Kit; Pseudoachondroplasia ELISA Kit; THBS 5 ELISA Kit; THBS5 ELISA Kit; Thrombospondin 5 ELISA Kit; Thrombospondin-5 ELISA Kit; Thrombospondin5 ELISA Kit; TSP5 ELISA Kit
  • 缩写:
  • Uniprot No.:
  • 种属:
    Homo sapiens (Human)
  • 样本类型:
    serum, plasma, tissue homogenates
  • 检测范围:
    0.156 ng/ml-10 ng/ml
  • 灵敏度:
    0.039 ng/ml
  • 反应时间:
    1-5h
  • 样本体积:
    50-100ul
  • 检测波长:
    450 nm
  • 研究领域:
    Cell Biology
  • 测定原理:
    quantitative
  • 测定方法:
    Sandwich
  • 精密度:

      
     

  • 线性度:

     

  • 回收率:

     

  • 标准曲线:

     
     

  • 数据处理:
  • 货期:
    3-5 working days

引用文献

产品评价

靶点详情

  • 最新研究进展:
    COMP(Cartilage oligomeric matrix protein),又称为Thrombospondin-5 (TSP5),是一种含有多个结构域的分子,属于类胶原蛋白家族。它主要在软骨、肌腱和韧带中表达,并在软骨发育、修复和代谢过程中起着重要作用。最近的研究表明,血液中的COMP水平可作为炎症和代谢性疾病的标志物,如类风湿关节炎、膝关节骨性关节炎和2型糖尿病等。
     
  • 功能:
    May play a role in the structural integrity of cartilage via its interaction with other extracellular matrix proteins such as the collagens and fibronectin. Can mediate the interaction of chondrocytes with the cartilage extracellular matrix through interaction with cell surface integrin receptors. Could play a role in the pathogenesis of osteoarthritis. Potent suppressor of apoptosis in both primary chondrocytes and transformed cells. Suppresses apoptosis by blocking the activation of caspase-3 and by inducing the IAP family of survival proteins (BIRC3, BIRC2, BIRC5 and XIAP). Essential for maintaining a vascular smooth muscle cells (VSMCs) contractile/differentiated phenotype under physiological and pathological stimuli. Maintains this phenotype of VSMCs by interacting with ITGA7.
  • 基因功能参考文献:
    1. Adolescent idiopathic scoliosis patients had significantly high COMP promoter methylation and low gene expression. Positive and high COMP promoter methylation was correlated with young age and high Cobb angle of main curve PMID: 28951969
    2. Our findings indicated that hepatic stellate cells-derived COMP collaborated with CD36 and subsequently played an essential role in MEK/ERK and PI3K/AKT-mediated hepatocellular carcinoma (HCC) progression. COMP might act as a promising target for the diagnosis and treatment of aggressive HCC. PMID: 30231922
    3. These findings suggest that Zalpha domain of human ADAR1 binding with the GAC hairpin stem in COMP can lead to a non-genetic, RNA editing-mediated substitution in COMP that may then play a crucial role in the development of pseudoachondroplasia. PMID: 28924040
    4. Higher serum COMP levels in knee osteoarthritis reflect knee structural damage. PMID: 29164307
    5. COMP (and C-reactive protein) serum levels were both associated with the incidence of knee osteoarthritis. PMID: 29351749
    6. Data indicate cartilage oligomeric matrix protein (COMP) homozygote missense variant [c.1423G>A; p.(D475N)] in 2 severely affected pseudoachondroplasia individuals. PMID: 28685811
    7. The serum COMP is a promising biomarker in rheumatoid arthritis which reflects disease activity and damage to the articular cartilage. PMID: 28889184
    8. COMP promoted colon cancer cell proliferation partially through the activation of PI3K/ Akt/ mTOR/ p70S6K pathway. PMID: 29560517
    9. The findings suggest that upregulation of ADAMTS-7 and down regulation of COMP are associated with human AA. PMID: 28849199
    10. Data show that a rare missense variant in the COMP gene (cartilage oligomeric matrix protein) and a frameshift variant in the CHADL gene (chondroadherin-like protein) strongly associate with osteoarthritis total hip replacement. PMID: 28319091
    11. COMP is a novel biomarker in breast cancer, which contributes to the severity of the disease by metabolic switching and increasing invasiveness and tumor cell viability, leading to reduced survival in animal models and human patients. PMID: 27065333
    12. The average sCOMP level was highest among the controls and lowest among the infected children. In the juvenile idiopathic arthritis patients, the level of sCOMP was not associated with the level of CRP or with clinical signs of disease activity. PMID: 27385219
    13. COMT Val158Met polymorphism may influence responses to dextromethorphan (30 mg/d) by decreasing depressive symptoms in BD patients. PMID: 27930497
    14. The serum COMP level has the potential to be used as a biological marker for differentiating between patients with rheumatoid arthritis and healthy individuals. PMID: 27217240
    15. The current study expanded the mutation spectrum of the COMP gene, and contributes to the understanding of phenotype/genotype of COMPassociated diseases. PMID: 27432013
    16. In the absence of ultrasonographic knee cartilage deformation, the response of serum lubricin and COMP following acute vigorous exercise indicates an increase in joint lubrication and cartilage metabolism, respectively, which appears largely independent of exercise modality. PMID: 27251407
    17. Running appears to decrease knee intra-articular pro-inflammatory cytokine concentration and facilitates the movement of COMP from the joint space to the serum. PMID: 27699484
    18. Results suggest that serum oligomeric matrix protein and hyaluronic acid (COMP and HA) concentrations can be used to predict early cartilage lesions in the knee. PMID: 26634947
    19. Serum COMP levels are predictive of subsequent structural changes and incidence of painful knee osteoarthritis. PMID: 26848781
    20. The expression of COMP in circulation reflects the severity of rheumatoid arthritis. PMID: 27455560
    21. findings suggest that Cartilage oligomeric matrix protein (COMP) is associated with the stage of liver fibrosis in chronic hepatitis C PMID: 26269256
    22. The GG genotype of Med23 gene associate with Cognitive Decline and Dementia. PMID: 25835418
    23. determined if structural differences of the TSPs imparted different effects on vascular smooth muscle cell functions critical to the formation of neointimal hyperplasia PMID: 26168731
    24. COMP does not directly modify the expression of genes involved in cartilage homeostasis in contrast to several other cartilage matrix proteins. PMID: 25111190
    25. Overexpression of COMP inhibits BMP-2-induced osteogenic differentiation and promotes BMP-2-induced chondrogenic differentiation. PMID: 25430711
    26. Real-time polymerase chain reaction (RT-PCR) assay presented significantly higher (p<0.01) COMP expression of mesenchymal stem cells cultured with HA/COMP multilayered films. PMID: 25380520
    27. Mutations in specific residues and/or regions of the type III repeats of COMP are significantly associated with either Pseudoachondroplasia or multiple epiphyseal dysplasia. PMID: 24595329
    28. Serum COMP was not acutely influenced by experimental anterior knee pain during running. PMID: 24907621
    29. Novel cartilage oligomeric matrix protein (COMP) neoepitopes identified in synovial fluids from patients with joint diseases using affinity chromatography and mass spectrometry. PMID: 24917676
    30. Variants within the cartilage oligomeric matrix protein (COMP) gene are not associated with Achilles tendinopathy PMID: 23875975
    31. COMP-C3b complexes are found in the serum of patients with systemic sclerosis PMID: 24330664
    32. COMP is up-regulated in idiopathic pulmonary fibrosis. PMID: 24376648
    33. COMP-C3b levels were higher in patients with rheumatoid arthritis than in healthy controls and lower in extraarticular rheumatoid arthritis (ExRA) than in rheumatoid arthritis controls. PMID: 24187101
    34. Athletes with femoroacetabular impingement had a 24% increase in plasma COMP levels. PMID: 23959964
    35. A mutation c.1048_1116del in exon 10, inherited from his father who did not demonstrate any phenotypic feature of PSACH PMID: 24229584
    36. Enhanced deposition of COMP is a common feature in fibrotic skin pathologies. PMID: 23507196
    37. This study demonstrates that COMP enhances the osteogenic activity of BMP-2, both in-vitro and in-vivo. PMID: 23528838
    38. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis. PMID: 23915292
    39. DNA sequencing analysis of the COMP gene revealed a heterozygous mutation. PMID: 23562786
    40. serum levels of COMP in Kashin-Beck disease were increased compared with healthy controls, but lower than in osteoarthritis patients, and the increase was not correlated with disease severity. PMID: 22068351
    41. COMPcc may be involved in signalling functions in which hydrophilic ligands are involved PMID: 23133613
    42. The proximal 3 Kb of the human cartilage oligomeric matrix protein promoter is sufficient to mediate a mechanoresponse in human articular chondrocytes and stem cells. PMID: 22764748
    43. Data indicate that cartilage oligomeric matrix protein (COMP-C3b levels are elevated in several rheumatologic diseases and correlate with inflammatory measures in rheumatoid arthritis (RA). PMID: 22264230
    44. Serum COMP was not related to endothelial function in patients with rheumatoid arthritis , or to other cardiovascular risk factors studied. PMID: 22660798
    45. Detection of cartilage oligomeric matrix protein using a quartz crystal microbalance. PMID: 22163547
    46. Serum COMP early in disease is a predictor of mortality in systemic sclerosis patients. PMID: 22253028
    47. Type III repeat region COMP mutations have been identified in 27 of the 28 patients with pseudoachondroplasia. COMP mutations have been identified in 37 patients with multiple epiphyseal dysplasia, which were distributed between nine exons. PMID: 21922596
    48. Study conclude that TGF-beta1 binds to COMP and that TGF-beta1 bound to COMP has enhanced bioactivity. PMID: 21940632
    49. Radiographic findings in patients with COMP and MATN3 mutations showed marked abnormalities in hip and knee joints. PMID: 21965141
    50. COMP facilitates keloid formation by accelerating collagen deposition, thus providing a new therapeutic target. PMID: 21872564

    显示更多

    收起更多

  • 相关疾病:
    Multiple epiphyseal dysplasia 1 (EDM1); Pseudoachondroplasia (PSACH)
  • 亚细胞定位:
    Secreted, extracellular space, extracellular matrix.
  • 蛋白家族:
    Thrombospondin family
  • 组织特异性:
    Abundantly expressed in the chondrocyte extracellular matrix, and is also found in bone, tendon, ligament and synovium and blood vessels. Increased amounts are produced during late stages of osteoarthritis in the area adjacent to the main defect.
  • 数据库链接:

    HGNC: 2227

    OMIM: 132400

    KEGG: hsa:1311

    STRING: 9606.ENSP00000222271

    UniGene: Hs.1584